tradingkey.logo
tradingkey.logo
検索

Nanovibronix Inc

NAOV
ウォッチリストに追加
4.020USD
0.0000.00%
終値 07/02, 13:00ET15分遅れの株価
3.17M時価総額
損失額直近12ヶ月PER

詳細情報 Nanovibronix Inc 企業名

NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.

Nanovibronix Incの企業情報

企業コードNAOV
会社名Nanovibronix Inc
上場日Apr 24, 2015
最高経営責任者「CEO」Besser (Doron)
従業員数15
証券種類Ordinary Share
決算期末Apr 24
本社所在地969 Pruitt Piace
都市TYLER
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号75703
電話番号19142333004
ウェブサイトhttps://nanovibronix.com/
企業コードNAOV
上場日Apr 24, 2015
最高経営責任者「CEO」Besser (Doron)

Nanovibronix Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
--
-100.00%
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
--
-100.00%
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--

よくある質問

Nanovibronix Incの上位5名の株主は誰ですか?

Nanovibronix Incの上位5名の株主は以下のとおりです。Dr. Harold Jacob, M.D.

Nanovibronix Inc(NAOV)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Nanovibronix Incの株式を保有している機関は17社あり、保有株式の総市場価値は約44.60Kで、全体の1.21%を占めています。2025Q4と比較して、機関の持ち株は33009.00増加しています。